Family Medicine Doctors in Sun Lakes, AZ Accepting Medicare

5 Family Medicine doctors found. Showing 1 - 5

Roger P Rose, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 10440 E Riggs Rd Ste 203, Sun Lakes, AZ 85248 Phone: 480-378-2253    Fax: 480-378-3658

Kenneth D Paige, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 10450 E Riggs Rd #114, Sun Lakes, AZ 85248 Phone: 480-505-2450    Fax: 480-505-2465

Jennifer S Mcdonald, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 10450 E Riggs Rd, Bldg 6, Ste 114, Sun Lakes, AZ 85248 Phone: 480-505-2450    Fax: 480-505-2465

Hal L Kime, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 26434 S Hogan Dr, Sun Lakes, AZ 85248 Phone: 480-883-0699

Angela L. Hinds, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 10440 E Riggs Rd, Sun Lakes, AZ 85248 Phone: 480-883-3640    Fax: 480-883-3643

News Archive

Protalix Biotherapeutics completes NDA submission for taliglucerase alfa

Protalix Biotherapeutics, Inc. today announced the completion of its New Drug Application (NDA) submission with the U.S. Food and Drug Administration (FDA) for taliglucerase alfa, a plant-cell expressed form of glucocerebrosidase (GCD) for the potential treatment of Gaucher's disease.

Study seeks to determine environmental factors that protect against asthma, allergies

Researchers in the University of Arizona's BIO5 Institute have entered into a collaboration with Johnson & Johnson Consumer & Personal Products and Janssen Biotech Inc. to leverage foundational discovery research aimed at determining environmental factors that underlie asthma and allergies.

Bipolar survey indicates how patient satisfaction is achieved

Preliminary results from a large-scale global study of people living with bipolar disorder, presented today at the World Congress of Biological Psychiatry (WCBP), found that patient satisfaction with treatment is achieved through combining broad-based efficacy with a favourable tolerability profile.

FluCide nanoviricide drug reduces overall leukocytes in lung tissue of influenza model

NanoViricides, Inc. reports that post-infection treatment with its optimized FluCide drug candidates resulted in significant reduction in lung tissue presence of leukocytes, and in particular, that of eosinophils in a lethal influenza infection animal model.

Impact of health law on costs reaches beyond premium pricetags

Much of the debate about the overhaul's costs has focused on "rate shock," but other issues also are in play.

Read more Medical News

› Verified 8 days ago